In a report released on February 21, James Kammert from Evercore ISI reiterated a Buy rating on VICI Properties (VICI – Research Report), with ...
BioCryst Pharmaceuticals (NASDAQ:BCRX – Get Free Report) is expected to post its quarterly earnings results before the market ...
Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report)‘s stock had its “outperform” rating reiterated by stock analysts at Wedbush in a research note issued to investors on Friday,RTT News reports.